Shares of Moderna, Inc. MRNA may be in trouble. The stock has run into resistance around the $350 level. The last time this happened, a sell-off followed.
Resistance is a large group of sellers who are offering their shares at or close to the same price. In this case, it’s $350.
At resistance levels, there is more supply than there is demand for a stock. This is why rallies end when they reach them.
Sometimes, after a stock hits a resistance level the price goes down after. This is what happened to Moderna when the stock reached $350 earlier this month. Now it may happen again soon.
To learn more about charts and check out the new Benzinga Trading School.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
